BEAM
Price
$28.50
Change
-$0.08 (-0.28%)
Updated
Dec 18, 10:59 AM (EDT)
76 days until earnings call
LGND
Price
$120.28
Change
-$2.06 (-1.68%)
Updated
Dec 17, 04:59 PM (EDT)
50 days until earnings call
Ad is loading...

BEAM vs LGND

Header iconBEAM vs LGND Comparison
Open Charts BEAM vs LGNDBanner chart's image
Beam Therapeutics
Price$28.50
Change-$0.08 (-0.28%)
Volume$9.15K
CapitalizationN/A
Ligand Pharmaceuticals
Price$120.28
Change-$2.06 (-1.68%)
Volume$3.82K
CapitalizationN/A
BEAM vs LGND Comparison Chart
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LGND
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. LGND commentary
Dec 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and LGND is a StrongBuy.

COMPARISON
Comparison
Dec 18, 2024
Stock price -- (BEAM: $28.58 vs. LGND: $120.43)
Brand notoriety: BEAM and LGND are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 130% vs. LGND: 108%
Market capitalization -- BEAM: $2.37B vs. LGND: $2.28B
BEAM [@Biotechnology] is valued at $2.37B. LGND’s [@Biotechnology] market capitalization is $2.28B. The market cap for tickers in the [@Biotechnology] industry ranges from $486.73B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 0 FA rating(s) are green whileLGND’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 0 green, 5 red.
  • LGND’s FA Score: 0 green, 5 red.
According to our system of comparison, LGND is a better buy in the long-term than BEAM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 5 TA indicator(s) are bullish while LGND’s TA Score has 4 bullish TA indicator(s).

  • BEAM’s TA Score: 5 bullish, 4 bearish.
  • LGND’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, both BEAM and LGND are a good buy in the short-term.

Price Growth

BEAM (@Biotechnology) experienced а -5.36% price change this week, while LGND (@Biotechnology) price change was +1.54% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.84%. For the same industry, the average monthly price growth was +1.08%, and the average quarterly price growth was +4.66%.

Reported Earning Dates

BEAM is expected to report earnings on Mar 04, 2025.

LGND is expected to report earnings on Feb 06, 2025.

Industries' Descriptions

@Biotechnology (-4.84% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.37B) and LGND($2.28B) have the same market capitalization . LGND YTD gains are higher at: 68.622 vs. BEAM (4.996).
BEAMLGNDBEAM / LGND
Capitalization2.37B2.28B104%
EBITDAN/AN/A-
Gain YTD4.99668.6227%
P/E RatioN/A48.37-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/A6.19M-
FUNDAMENTALS RATINGS
LGND: Fundamental Ratings
LGND
OUTLOOK RATING
1..100
19
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
PROFIT vs RISK RATING
1..100
48
SMR RATING
1..100
78
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
82
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMLGND
RSI
ODDS (%)
Bearish Trend 6 days ago
85%
Bearish Trend 8 days ago
76%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 3 days ago
78%
Momentum
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 3 days ago
79%
MACD
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 3 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 3 days ago
76%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 3 days ago
74%
Advances
ODDS (%)
Bullish Trend 9 days ago
81%
Bullish Trend 3 days ago
76%
Declines
ODDS (%)
Bearish Trend 6 days ago
85%
N/A
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
80%
Bullish Trend 3 days ago
82%
Aroon
ODDS (%)
N/A
Bullish Trend 3 days ago
81%
View a ticker or compare two or three
Ad is loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LGND
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

BEAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with CRSP. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
-1.21%
CRSP - BEAM
72%
Closely correlated
+0.88%
NTLA - BEAM
65%
Loosely correlated
-1.87%
DNLI - BEAM
65%
Loosely correlated
-0.30%
PRME - BEAM
62%
Loosely correlated
-3.00%
RXRX - BEAM
61%
Loosely correlated
-4.30%
More

LGND and

Correlation & Price change

A.I.dvisor indicates that over the last year, LGND has been loosely correlated with DNLI. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if LGND jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LGND
1D Price
Change %
LGND100%
-1.56%
DNLI - LGND
53%
Loosely correlated
-0.30%
VKTX - LGND
44%
Loosely correlated
-1.12%
JANX - LGND
41%
Loosely correlated
-3.17%
BEAM - LGND
39%
Loosely correlated
-1.21%
ACLX - LGND
38%
Loosely correlated
-1.67%
More